Evelyn Mikaela Kogawa1, Daniela Corrêa Grisi2, Denise Pinheiro Falcão3, Ingrid Aquino Amorim4, Taia Maria Berto Rezende5, Izabel Cristina Rodrigues da Silva6, Osmar Nascimento Silva7, Octávio Luiz Franco8, Rivadávio Fernandes Batista de Amorim9. 1. Programa de Pós-graduação em Ciências Médicas, Universidade de Brasília, Campus Universitário Darcy Ribeiro-Asa Norte, CEP 70910-900 Brasília-DF, Brazil; Curso de Odontologia, Universidade Católica de Brasília, QS 07 Lote 01 EPCT Campus I Bloco S, CEP 71966-700 Taguatinga-DF, Brazil. Electronic address: mikaela.kogawa@gmail.com. 2. Curso de Odontologia, Universidade Católica de Brasília, QS 07 Lote 01 EPCT Campus I Bloco S, CEP 71966-700 Taguatinga-DF, Brazil. Electronic address: dgrisi@terra.com.br. 3. Programa de Pós-graduação em Ciências Médicas, Universidade de Brasília, Campus Universitário Darcy Ribeiro-Asa Norte, CEP 70910-900 Brasília-DF, Brazil. Electronic address: dfalcao@terra.com.br. 4. Programa de Pós-Graduação em Ciências da Saúde, Universidade de Brasília, Campus Universitário Darcy Ribeiro-Asa Norte, CEP 70910-900 Brasília, Brazil; Centro de Análises Proteômicas e Bioquímicas, Pós-graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Campus avançado Asa Norte-SGAN 916 módulo B avenida W5CEP 70790-160 Brasília, Brazil. Electronic address: ingridaquinos2@gmail.com. 5. Curso de Odontologia, Universidade Católica de Brasília, QS 07 Lote 01 EPCT Campus I Bloco S, CEP 71966-700 Taguatinga-DF, Brazil; Programa de Pós-Graduação em Ciências da Saúde, Universidade de Brasília, Campus Universitário Darcy Ribeiro-Asa Norte, CEP 70910-900 Brasília, Brazil; Centro de Análises Proteômicas e Bioquímicas, Pós-graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Campus avançado Asa Norte-SGAN 916 módulo B avenida W5CEP 70790-160 Brasília, Brazil. Electronic address: taiambr@gmail.com. 6. FCE, Universidade de Brasília, Centro Metropolitano, conjunto A, lote 01, CEP 72220-900, Brasília, Brazil. Electronic address: belbiomedica@gmail.com. 7. Pós-graduação em Ciências Biológicas (Biotecnologia e Genética), Departamento de Biologia, Instituto de Ciências Biológicas, Universidade de Juiz de Fora, Rua José Lourenço Kelmer, s/n-Campus Universitário, CEP 36036-900, Juiz de Fora, Brazil. Electronic address: osmar.silva@catolica.edu.br. 8. Centro de Análises Proteômicas e Bioquímicas, Pós-graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Campus avançado Asa Norte-SGAN 916 módulo B avenida W5CEP 70790-160 Brasília, Brazil; Programa de Doutorado da Rede Centro-Oeste, Ministério da Ciência, Tecnologia e Inovação Esplanada dos Ministérios Bloco E, 2° andar, Sala 242, CEP 70067-900 Brasília, DF, Brazil; S-Inova, Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, CEP 79117-900 Campo Grande, MS, Brazil. Electronic address: ocfranco@gmail.com. 9. Programa de Pós-graduação em Ciências Médicas, Universidade de Brasília, Campus Universitário Darcy Ribeiro-Asa Norte, CEP 70910-900 Brasília-DF, Brazil. Electronic address: rivadavioamorim@hotmail.com.
Abstract
OBJECTIVE: To evaluate the effect of glycemic control status in type 2 diabetes mellitus (T2DM) individuals on clinical oral health indicators and to compare the concentrations of plasma and salivary chromogranin A (CHGA) among nondiabetic subjects and T2DM patients, exploring their associations. DESIGN: In this cross-sectional study, 32 patients with controlled T2DM, 31 with poorly controlled T2DM and 37 nondiabetic subjects underwent a clinical and periodontal examination. CHGA concentrations were determined in saliva and plasma with ELISA. RESULTS: Poorly controlled T2DM group exhibited significantly higher mean buffering capacity, plaque index and bleeding on probing than other groups (P<0.05). No difference was found to DMFT (decayed, missed and filled teeth) index between groups. Sites with clinical attachment loss (CAL) of 4 and 5-6mm were significantly higher in both diabetic groups compared to control group (P<0.05). Poorly controlled T2DM group had significantly higher sites with CAL ≥ 7 mm than other groups (P=0.001). Significantly higher plasma and salivary CHGA levels were found in T2DM groups (P<0.05). In both diabetic groups, probing depths 5-6mm and CAL 5-6mm were associated with higher salivary CHGA concentration (P<0.05). CONCLUSIONS: The findings revealed that T2DM patients were more prone to periodontal tissue damage than to caries risk. The results also provide some evidence that the degree of attachment loss deteriorates significantly with poor glycemic control in T2DM (CAL ≥ 7 mm). Moreover, the results suggest that high concentrations of salivary CHGA are associated with worse periodontal parameters and T2DM, and this could be related to the pathogenesis of both diseases.
OBJECTIVE: To evaluate the effect of glycemic control status in type 2 diabetes mellitus (T2DM) individuals on clinical oral health indicators and to compare the concentrations of plasma and salivary chromogranin A (CHGA) among nondiabetic subjects and T2DM patients, exploring their associations. DESIGN: In this cross-sectional study, 32 patients with controlled T2DM, 31 with poorly controlled T2DM and 37 nondiabetic subjects underwent a clinical and periodontal examination. CHGA concentrations were determined in saliva and plasma with ELISA. RESULTS: Poorly controlled T2DM group exhibited significantly higher mean buffering capacity, plaque index and bleeding on probing than other groups (P<0.05). No difference was found to DMFT (decayed, missed and filled teeth) index between groups. Sites with clinical attachment loss (CAL) of 4 and 5-6mm were significantly higher in both diabetic groups compared to control group (P<0.05). Poorly controlled T2DM group had significantly higher sites with CAL ≥ 7 mm than other groups (P=0.001). Significantly higher plasma and salivary CHGA levels were found in T2DM groups (P<0.05). In both diabetic groups, probing depths 5-6mm and CAL 5-6mm were associated with higher salivary CHGA concentration (P<0.05). CONCLUSIONS: The findings revealed that T2DM patients were more prone to periodontal tissue damage than to caries risk. The results also provide some evidence that the degree of attachment loss deteriorates significantly with poor glycemic control in T2DM (CAL ≥ 7 mm). Moreover, the results suggest that high concentrations of salivary CHGA are associated with worse periodontal parameters and T2DM, and this could be related to the pathogenesis of both diseases.
Authors: Ekta A Malvania; Sona A Sheth; Ashish S Sharma; Saloni Mansuri; Faizan Shaikh; Saloni Sahani Journal: J Int Soc Prev Community Dent Date: 2016-12
Authors: Elke M Muntjewerff; Gina Dunkel; Mara J T Nicolasen; Sushil K Mahata; Geert van den Bogaart Journal: Front Immunol Date: 2018-10-04 Impact factor: 7.561
Authors: Thais de Cássia Negrini; Iracilda Zeppone Carlos; Cristiane Duque; Karina Sampaio Caiaffa; Rodrigo Alex Arthur Journal: Front Oral Health Date: 2021-09-09